Abstract
Invasive mould infections are a major cause of infectious mortality in highly immunosuppressed patients. Incidence in this high risk group is 10-20% with a death rate in excess of 50%. Most invasive moulds are Aspergillus spp. We present a case of a 74-year-old woman with acute lymphoblastic leukaemia who developed a rare disseminated mould infection with Fusarium solani during induction chemotherapy. We present the case story and discuss the pathogenesis, clinical characteristics and treatment of invasive fusariosis.
| Bidragets oversatte titel | Disseminated fusariosis in a patient with acute lymphoblastic leukaemia |
|---|---|
| Originalsprog | Dansk |
| Tidsskrift | Ugeskrift for Laeger |
| Vol/bind | 170 |
| Udgave nummer | 37 |
| Sider (fra-til) | 2892 |
| Antal sider | 2 |
| ISSN | 0041-5782 |
| Status | Udgivet - 8 sep. 2008 |
Emneord
- Aged
- Antifungal Agents/administration & dosage
- Antineoplastic Combined Chemotherapy Protocols/adverse effects
- Dermatomycoses/drug therapy
- Fatal Outcome
- Female
- Fusarium/isolation & purification
- Humans
- Immunocompromised Host
- Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy
Fingeraftryk
Dyk ned i forskningsemnerne om 'Dissemineret fusariose hos en patient med akut lymfoblastaer leukaemi'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS